The safety of antidepressant drugs during pregnancy
@article{Klln2007TheSO, title={The safety of antidepressant drugs during pregnancy}, author={B. K{\"a}ll{\'e}n}, journal={Expert Opinion on Drug Safety}, year={2007}, volume={6}, pages={357 - 370} }
This article discusses known or suspected effects of maternal use of antidepressants during pregnancy on pregnancy outcome. It is unlikely that any marked teratogenic effect occurs with the possible exception of an increased risk for cardiovascular defects after maternal use of clomipramine or paroxetine. An increased risk for preterm birth is seen. Transient neonatal symptoms are common after the use of antidepressants in late pregnancy. Few firm data are available on the possible impact on… CONTINUE READING
Topics from this paper
30 Citations
Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data.
- Medicine
- Psychological medicine
- 2010
- 295
Maternal Use of Antipsychotics in Early Pregnancy and Delivery Outcome
- Medicine
- Journal of clinical psychopharmacology
- 2008
- 184
Maternal use of selective serotonin re‐uptake inhibitors and persistent pulmonary hypertension of the newborn
- Medicine
- Pharmacoepidemiology and drug safety
- 2008
- 165
Antidepressant Use During Pregnancy and the Risk of Preterm Delivery and Fetal Growth Restriction
- Medicine
- Journal of clinical psychopharmacology
- 2009
- 71
References
SHOWING 1-10 OF 104 REFERENCES
Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials.
- Medicine
- Reproductive toxicology
- 2006
- 119
The Use of Selective Serotonin Reuptake Inhibitors During Pregnancy and Breast-feeding: A Review and Clinical Aspects
- Medicine
- Journal of clinical psychopharmacology
- 2005
- 118
Delivery outcome after the use of antidepressants in early pregnancy
- Medicine
- European Journal of Clinical Pharmacology
- 1999
- 286
Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.
- Medicine
- Birth defects research. Part A, Clinical and molecular teratology
- 2007
- 262
Birth outcomes after prenatal exposure to antidepressant medication.
- Medicine
- American journal of obstetrics and gynecology
- 2003
- 199
Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.
- Medicine
- JAMA
- 1998
- 315
- PDF
Perinatal outcome following third trimester exposure to paroxetine.
- Medicine
- Archives of pediatrics & adolescent medicine
- 2002
- 192
- PDF
Delivery Outcome in Relation to Maternal Use of Some Recently Introduced Antidepressants
- Medicine
- Journal of clinical psychopharmacology
- 2007
- 108
First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
- Medicine
- Birth defects research. Part B, Developmental and reproductive toxicology
- 2007
- 263
Risks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy
- Medicine
- Obstetrics and gynecology
- 2005
- 207
- Highly Influential